Our previous studies though showed that CD24+CD44+ cells isolated from a human pancreatic carcinoma cell line (PANC-1) had 4-fold increased invasion ability compared to CD24-CD44+ cells [40]. This evidence concerns the gene CD44 and exocrine pancreatic carcinoma.